A review of the use of psychotropic medication in pregnancy
- PMID: 21897237
- DOI: 10.1097/GCO.0b013e32834b92f3
A review of the use of psychotropic medication in pregnancy
Abstract
Purpose of review: There is increasing awareness within obstetric services of the importance of treating maternal mental illness due to the association with increased maternal mortality, morbidity and poorer child outcomes. However, there is limited research on the risks and benefits of pharmacological treatment of women in pregnancy. This review is focused on studies published in the past 18 months.
Recent findings: Antidepressants and antiepileptic mood stabilizers are the most frequently studied of the pharmacological treatments for mental illness. There are clear risks of neonatal serotonin discontinuation symptoms associated with antenatal antidepressant use. It remains unclear whether there is an elevated risk of malformations, persistent pulmonary hypertension of the newborn, prematurity, low birth weight and negative child developmental outcomes. Mood stabilizers have been associated with an increased malformation risk and some are associated with poorer neonatal and child developmental outcomes. There are available only limited studies on antipsychotics in pregnancy.
Summary: Given the limited research on psychotropic medication in pregnancy, each woman, in collaboration with her clinician, needs to consider the risks in the context of her individual circumstances. However, any consideration of the risks of pharmacological treatment must be considered in relation to the risks associated with untreated mental illness.
Similar articles
-
[Current evaluation of teratogenic and fetotoxic effects of psychotropic drugs].Seishin Shinkeigaku Zasshi. 2014;116(12):996-1004. Seishin Shinkeigaku Zasshi. 2014. PMID: 25823351 Review. Japanese.
-
Risks/safety of psychotropic medication use during pregnancy--Motherisk Update 2008.Can J Clin Pharmacol. 2009 Winter;16(1):e58-65. Epub 2009 Jan 22. Can J Clin Pharmacol. 2009. PMID: 19164847 Review.
-
Neurodevelopmental effects of prenatal exposure to psychotropic medications.Depress Anxiety. 2010 Jul;27(7):675-86. doi: 10.1002/da.20706. Depress Anxiety. 2010. PMID: 20583298 Review.
-
Psychotropic medication during pregnancy and lactation.Arch Gynecol Obstet. 2008 Jan;277(1):1-13. doi: 10.1007/s00404-007-0433-2. Epub 2007 Aug 21. Arch Gynecol Obstet. 2008. PMID: 17710428 Review.
-
Psychotropic drug use during pregnancy: weighing the risks.J Clin Psychiatry. 1998;59 Suppl 2:18-28. J Clin Psychiatry. 1998. PMID: 9559756 Review.
Cited by
-
Women with epilepsy: clinically relevant issues.Funct Neurol. 2016 Jul-Sep;31(3):127-34. doi: 10.11138/fneur/2016.31.3.127. Funct Neurol. 2016. PMID: 27678205 Free PMC article. Review.
-
The Patterns of Antipsychotic Use for Pregnant Women Over a 16-year Timeframe in an Australian Principal Referral and Specialist Women and Newborn Hospital.Psychiatr Q. 2023 Mar;94(1):23-32. doi: 10.1007/s11126-022-10012-9. Epub 2022 Dec 20. Psychiatr Q. 2023. PMID: 36536267
-
Mercy Pregnancy and Emotional Well-being Study (MPEWS): Understanding maternal mental health, fetal programming and child development. Study design and cohort profile.Int J Methods Psychiatr Res. 2017 Dec;26(4):e1558. doi: 10.1002/mpr.1558. Epub 2017 Jan 25. Int J Methods Psychiatr Res. 2017. PMID: 28120519 Free PMC article.
-
Perinatal Maternal Mental Health, Fetal Programming and Child Development.Healthcare (Basel). 2015 Nov 26;3(4):1212-27. doi: 10.3390/healthcare3041212. Healthcare (Basel). 2015. PMID: 27417821 Free PMC article. Review.
-
Further findings linking SSRIs during pregnancy and persistent pulmonary hypertension of the newborn: clinical implications.CNS Drugs. 2012 Oct 1;26(10):813-22. doi: 10.2165/11630310-000000000-00000. CNS Drugs. 2012. PMID: 22950489 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous